Literature DB >> 11190811

Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications.

G Acs1, T J Lawton, T R Rebbeck, V A LiVolsi, P J Zhang.   

Abstract

We studied the pattern of E-cadherin expression in 183 invasive carcinomas (100 ductal, 42 lobular, 41 with mixed ductal and lobular features) and 198 in situ carcinomas (131 ductal, 53 lobular, 14 in situ with ductal and lobular features) by immunohistochemistry. We found a highly significant correlation of E-cadherin membrane expression with the histologic phenotype of the tumors. While moderate to strong membrane expression of E-cadherin was seen in all invasive and in situ ductal carcinomas, 41 of 42 invasive and 50 of 53 in situ lobular carcinomas showed complete loss of expression. All in situ carcinomas diagnosed histologically as showing mixed ductal and lobular features demonstrated complete loss of staining. Invasive carcinomas with ductal and lobular features showed 3 staining patterns: (1) complete or almost complete lack of membrane staining similar to that seen in lobular carcinomas, (2) uniform membrane expression throughout the tumor similar to ductal carcinomas, and (3) focal loss of E-cadherin staining, which correlated well with the histologic impression of focal lobular features. In tumors with histologically equivocal features, immunohistochemical detection of E-cadherin expression can be a useful diagnostic tool for the differentiation of ductal and lobular carcinomas of the breast.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11190811     DOI: 10.1309/FDHX-L92R-BATQ-2GE0

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  51 in total

1.  E-cadherin immunohistochemical expression in invasive lobular carcinoma of the breast: correlation with morphology and CDH1 somatic alterations.

Authors:  Anne Grabenstetter; Abhinita S Mohanty; Satshil Rana; Ahmet Zehir; A Rose Brannon; Timothy M D'Alfonso; Deborah F DeLair; Lee K Tan; Dara S Ross
Journal:  Hum Pathol       Date:  2020-06-26       Impact factor: 3.466

2.  Risk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening population.

Authors:  Amanda I Phipps; Christopher I Li; Karla Kerlikowske; William E Barlow; Diana S M Buist
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-05-25       Impact factor: 4.254

3.  [Concepts and problems of lobular neoplasia].

Authors:  H P Sinn; B Helmchen; S Aulmann
Journal:  Pathologe       Date:  2006-09       Impact factor: 1.011

4.  Genetic variations in the Hippo signaling pathway and breast cancer risk in African American women in the AMBER Consortium.

Authors:  Jianmin Zhang; Song Yao; Qiang Hu; Qianqian Zhu; Song Liu; Kathryn L Lunetta; Stephen A Haddad; Nuo Yang; He Shen; Chi-Chen Hong; Lara Sucheston-Campbell; Edward A Ruiz-Narvaez; Jeannette T Bensen; Melissa A Troester; Elisa V Bandera; Lynn Rosenberg; Christopher A Haiman; Andrew F Olshan; Julie R Palmer; Christine B Ambrosone
Journal:  Carcinogenesis       Date:  2016-08-01       Impact factor: 4.944

Review 5.  Significance of immunohistochemistry in breast cancer.

Authors:  Dana Carmen Zaha
Journal:  World J Clin Oncol       Date:  2014-08-10

6.  Alcohol consumption and risk of postmenopausal breast cancer by subtype: the women's health initiative observational study.

Authors:  Christopher I Li; Rowan T Chlebowski; Matthew Freiberg; Karen C Johnson; Lewis Kuller; Dorothy Lane; Lawrence Lessin; Mary Jo O'Sullivan; Jean Wactawski-Wende; Shagufta Yasmeen; Ross Prentice
Journal:  J Natl Cancer Inst       Date:  2010-08-23       Impact factor: 13.506

7.  Invasive ductal carcinoma with lobular features: a comparison study to invasive ductal and invasive lobular carcinomas of the breast.

Authors:  David P Arps; Patrick Healy; Lili Zhao; Celina G Kleer; Judy C Pang
Journal:  Breast Cancer Res Treat       Date:  2013-03-28       Impact factor: 4.872

8.  Invasive lobular carcinoma with extracellular mucin production and HER-2 overexpression: a case report and further case studies.

Authors:  Jing Yu; Rohit Bhargava; David J Dabbs
Journal:  Diagn Pathol       Date:  2010-06-15       Impact factor: 2.644

9.  Expression analysis of E-cadherin, Slug and GSK3beta in invasive ductal carcinoma of breast.

Authors:  Chandra P Prasad; Gayatri Rath; Sandeep Mathur; Dinesh Bhatnagar; Rajinder Parshad; Ranju Ralhan
Journal:  BMC Cancer       Date:  2009-09-14       Impact factor: 4.430

10.  Clinicopathological study of male breast carcinoma: 24 years of experience.

Authors:  Parveen Shah; Irfan Robbani; Omar Shah
Journal:  Ann Saudi Med       Date:  2009 Jul-Aug       Impact factor: 1.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.